viru
zikv
recent
epidem
presum
result
initi
zoonot
animaltohuman
transmiss
event
either
clinic
appar
occult
spread
vulner
human
popul
time
lack
rapid
access
accur
molecular
diagnost
test
hinder
public
health
respons
emerg
viral
threat
earli
januari
cluster
case
pneumonia
novel
coronaviru
diseas
refer
report
wuhan
china
outbreak
spread
rapidli
report
case
death
march
persontoperson
transmiss
infect
individu
mild
symptom
report
assay
use
quantit
revers
transcriptionpolymeras
chain
reaction
qrtpcr
approach
detect
viru
hour
develop
sever
laboratori
includ
emerg
use
author
eua
approv
assay
develop
us
cdc
howev
typic
turnaround
time
screen
diagnos
patient
suspect
hour
given
need
ship
sampl
overnight
refer
laboratori
acceler
clinic
diagnost
test
unit
state
fda
februari
permit
individu
clinic
licens
laboratori
report
result
inhous
develop
diagnost
assay
await
result
eua
submiss
approv
report
develop
initi
valid
crispr
cluster
regularli
interspac
short
palindrom
repeat
base
assay
detect
extract
patient
sampl
rna
min
call
detectr
assay
perform
simultan
revers
transcript
isotherm
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
target
region
cdc
assay
longer
use
due
concern
regard
flaw
manufactur
reagent
potenti
decreas
sensit
next
compar
analyt
limit
detect
lod
detectr
assay
rel
us
fda
emerg
use
author
eua
approv
cdc
assay
detect
tabl
fig
standard
curv
quantit
construct
use
dilut
control
ivt
viral
nucleoprotein
rna
cdc
vtc
ncov
transcript
replic
dilut
fig
left
extend
data
ten
twofold
serial
dilut
control
nucleoprotein
rna
use
run
detectr
assay
replic
dilut
fig
right
supplementari
fig
estim
lod
cdc
assay
test
california
depart
public
health
reaction
consist
analyt
perform
fda
packag
insert
versu
reaction
detectr
assay
assess
capabl
rtlamp
assay
amplifi
nucleic
acid
directli
raw
sampl
matrix
consist
nasopharyng
swab
asymptomat
donor
place
univers
transport
medium
utm
phosphat
buffer
salin
pb
spike
ivt
target
rna
assay
perform
degrad
reaction
concentr
utm
pb
volum
estim
limit
detect
decreas
respect
supplementari
fig
final
test
extract
rna
respiratori
swab
sampl
collect
pcrposit
patient
anasopharyng
swab
boropharyng
swab
singl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
nasopharyng
swab
nasopharyng
swab
sampl
patient
influenza
common
human
season
coronaviru
infect
repres
healthi
donor
fig
f
supplementari
fig
rel
cdc
qrtpcr
detectr
sensit
specif
detect
coronaviru
respiratori
swab
sampl
correspond
posit
neg
predict
valu
respect
fig
combin
isotherm
amplif
detectr
technolog
develop
rapid
min
lowcost
test
detect
clinic
sampl
use
exist
qrtpcr
base
assay
hinder
need
expens
lab
instrument
avail
current
restrict
public
health
laboratori
importantli
detectr
assay
develop
compar
accuraci
qrtpcr
broadli
access
use
routin
protocol
commerci
avail
offtheshelf
reagent
key
advantag
approach
exist
method
qrtpcr
includ
isotherm
signal
amplif
rapid
target
detect
obviat
need
thermocycl
singl
nucleotid
target
specif
guid
rna
site
distinguish
sarscov
merscov
integr
portabl
lowcost
report
format
later
flow
strip
quick
develop
cycl
address
emerg
threat
novel
zoonot
virus
week
supplementari
fig
although
case
infect
first
month
epidem
trace
citi
wuhan
hubei
provinc
china
ongo
rise
case
appear
driven
local
commun
transmiss
number
reason
urgent
public
health
need
rapid
diagnost
test
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
interest
first
pcr
step
perform
synthet
gene
fragment
forward
primer
contain
promot
next
pcr
product
use
templat
invitro
transcript
ivt
reaction
hour
ivt
reaction
treat
turbo
dnase
thermo
min
follow
denatur
step
min
rna
purifi
use
rna
clean
dilut
nucleasefre
water
work
concentr
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
extend
data
standard
curv
gener
run
seven
dilut
cdc
qrtpcr
assay
replic
dilut
rsquar
measur
correspond
regress
line
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
extend
data
primer
report
molecul
target
gene
fragment
guid
rna
use
studi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
